Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology
- PMID: 1625004
- DOI: 10.3171/jns.1992.77.2.0169
Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology
Abstract
This article examines the pathophysiology of lesions caused by focal cerebral ischemia. Ischemia due to middle cerebral artery occlusion encompasses a densely ischemic focus and a less densely ischemic penumbral zone. Cells in the focus are usually doomed unless reperfusion is quickly instituted. In contrast, although the penumbra contains cells "at risk," these may remain viable for at least 4 to 8 hours. Cells in the penumbra may be salvaged by reperfusion or by drugs that prevent an extension of the infarction into the penumbral zone. Factors responsible for such an extension probably include acidosis, edema, K+/Ca++ transients, and inhibition of protein synthesis. Central to any discussion of the pathophysiology of ischemic lesions is energy depletion. This is because failure to maintain cellular adenosine triphosphate (ATP) levels leads to degradation of macromolecules of key importance to membrane and cytoskeletal integrity, to loss of ion homeostasis, involving cellular accumulation of Ca++, Na+, and Cl-, with osmotically obligated water, and to production of metabolic acids with a resulting decrease in intra- and extracellular pH. In all probability, loss of cellular calcium homeostasis plays an important role in the pathogenesis of ischemic cell damage. The resulting rise in the free cytosolic intracellular calcium concentration (Ca++) depends on both the loss of calcium pump function (due to ATP depletion), and the rise in membrane permeability to calcium. In ischemia, calcium influx occurs via multiple pathways. Some of the most important routes depend on activation of receptors by glutamate and associated excitatory amino acids released from depolarized presynaptic endings. However, ischemia also interfers with the intracellular sequestration and binding of calcium, thereby contributing to the rise in intracellular Ca++. A second key event in the ischemic tissue is activation of anaerobic glucolysis. The main reason for this activation is inhibition of mitochondrial metabolism by lack of oxygen; however, other factors probably contribute. For example, there is a complex interplay between loss of cellular calcium homeostasis and acidosis. On the one hand, a rise in intracellular Ca++ is apt to cause mitochondrial accumulation of calcium. This must interfere with ATP production and enhance anaerobic glucolysis. On the other hand, acidosis must interfere with calcium binding, thereby contributing to the rise in intracellular Ca++.
Republished in
-
Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. (1992).J Neurosurg. 2008 Mar;108(3):616-31. doi: 10.3171/JNS/2008/108/3/0616. J Neurosurg. 2008. PMID: 18312115
Similar articles
-
Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. (1992).J Neurosurg. 2008 Mar;108(3):616-31. doi: 10.3171/JNS/2008/108/3/0616. J Neurosurg. 2008. PMID: 18312115
-
Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment.J Neurosurg. 1992 Sep;77(3):337-54. doi: 10.3171/jns.1992.77.3.0337. J Neurosurg. 1992. PMID: 1506880 Review.
-
Epileptic brain damage: pathophysiology and neurochemical pathology.Adv Neurol. 1986;44:813-47. Adv Neurol. 1986. PMID: 2871725 Review.
-
The biochemical basis of ischemic brain lesions.Arzneimittelforschung. 1991 Mar;41(3A):288-92. Arzneimittelforschung. 1991. PMID: 1859497 Review.
-
Perinatal brain injury.J Perinat Med. 2000;28(4):261-85. doi: 10.1515/JPM.2000.034. J Perinat Med. 2000. PMID: 11031697 Review.
Cited by
-
NR2B-dependent cyclophilin D translocation suppresses the recovery of synaptic transmission after oxygen-glucose deprivation.Biochim Biophys Acta. 2015 Oct;1852(10 Pt A):2225-2234. doi: 10.1016/j.bbadis.2015.07.019. Epub 2015 Jul 29. Biochim Biophys Acta. 2015. PMID: 26232180 Free PMC article.
-
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke.Front Cell Neurosci. 2020 Jun 3;14:155. doi: 10.3389/fncel.2020.00155. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32581721 Free PMC article. Review.
-
Review of pharmacology and physiology in thrombolysis interventions.Semin Intervent Radiol. 2010 Dec;27(4):374-83. doi: 10.1055/s-0030-1267850. Semin Intervent Radiol. 2010. PMID: 22550379 Free PMC article.
-
Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia.J Mol Med (Berl). 2007 Jun;85(6):577-88. doi: 10.1007/s00109-007-0196-z. Epub 2007 Apr 11. J Mol Med (Berl). 2007. PMID: 17429598 Review.
-
Exploring Mechanisms of Houshiheisan in Treating Ischemic Stroke with Network Pharmacology and Independent Cascade Model.Comb Chem High Throughput Screen. 2024;27(7):959-968. doi: 10.2174/1386207326666230810094557. Comb Chem High Throughput Screen. 2024. PMID: 37565556
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources